Back
Garmin Vs. Akero Therapeutics Industry Stock Comparison
Buy
61
GRMN
Garmin
Last Price:
142.87
Seasonality Move:
5.65%
Sell
28
AKRO
Akero Therapeutics
Last Price:
20.30
Seasonality Move:
16.15%
Buy
61
Garmin (GRMN)
is a Buy
Is Garmin a Buy, Sell or Hold?
- The current Garmin [GRMN] share price is $142.51. The Score for GRMN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- GRMN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $21.00. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRMN Stock Price Chart
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $21.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.
GRMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.34 | Sell |
| Relative Strength Index (14 RSI): | 48.33 | Sell |
| Chaikin Money Flow: | 359083 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (142.45 - 148.13) | Sell |
| Bollinger Bands (100): | (122.59 - 142.65) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.18 | Sell |
| Relative Strength Index (14 RSI): | 35.31 | Sell |
| Chaikin Money Flow: | 33831 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.5 - 24.76) | Sell |
| Bollinger Bands (100): | (19.91 - 26.11) | Sell |
GRMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 141.47 | Buy |
| 20-day SMA: | 144.85 | Sell |
| 50-day SMA: | 140.77 | Buy |
| 200-day SMA: | 120.01 | Buy |
| 8-day EMA: | 142.09 | Buy |
| 20-day EMA: | 143.34 | Sell |
| 50-day EMA: | 140.18 | Buy |
| 200-day EMA: | 124.15 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.3 | Sell |
| 20-day SMA: | 22.6 | Sell |
| 50-day SMA: | 24.68 | Sell |
| 200-day SMA: | 29.2 | Sell |
| 8-day EMA: | 21.33 | Sell |
| 20-day EMA: | 22.52 | Sell |
| 50-day EMA: | 23.52 | Sell |
| 200-day EMA: | 27.68 | Sell |
Garmin Earnings Growth & GRMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.19 per share, an increase this year of $0.11 per share, and an increase next year of $0.64 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
Garmin Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||